FDA warns Curaleaf about inflated claims in CBD product marketing [Mdj2jlOANrW]

| 1h 28m 28s | Video has closed captioning.

A major medical marijuana company is under fire from the FDA. The agency sent Curaleaf a letter of warning over concerns that the cannabis company is marketing some of its products containing CBD as being effective treatments for cancer, Alzheimer's disease, opioid withdrawal and pain. #cbd gummies sour #is cbd gummies a scam

Aired: January 05, 2025

Rating: TV-14